| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute liver failure in low-income and middle-income countries
|
Vento, Sandro
|
|
|
8 |
11 |
p. 1035-1045
|
artikel
|
| 2 |
An important step towards the long-term treatment of eosinophilic oesophagitis
|
Marabotto, Elisa
|
|
|
8 |
11 |
p. 957-959
|
artikel
|
| 3 |
Bon additif: a culture of food processing
|
McQuillan, Cahal
|
|
|
8 |
11 |
p. 973
|
artikel
|
| 4 |
Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study
|
Kann, Anna Emilie
|
|
|
8 |
11 |
p. 1028-1034
|
artikel
|
| 5 |
Correction to Lancet Gastroenterol Hepatol 2023; 8: 976–89
|
|
|
|
8 |
11 |
p. e8
|
artikel
|
| 6 |
CROSS versus modified MAGIC or FLOT in oesophageal and gastro-oesophageal junction adenocarcinoma
|
van Rossum, Peter S N
|
|
|
8 |
11 |
p. 959-960
|
artikel
|
| 7 |
Diagnosis and management of ectopic varices in portal hypertension
|
Tranah, Thomas H
|
|
|
8 |
11 |
p. 1046-1056
|
artikel
|
| 8 |
Disease-free survival as the endpoint in multimodal rectal cancer trials: have we got this right?
|
Fokas, Emmanouil
|
|
|
8 |
11 |
p. 962-964
|
artikel
|
| 9 |
“Doing things our own way”: the road ahead for liver disease research and practice in Africa
|
Adepoju, Paul
|
|
|
8 |
11 |
p. 971
|
artikel
|
| 10 |
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
|
Rothenberg, Marc E
|
|
|
8 |
11 |
p. 990-1004
|
artikel
|
| 11 |
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
|
Vermeire, Séverine
|
|
|
8 |
11 |
p. 976-989
|
artikel
|
| 12 |
Expanding public health responses to non-communicable diseases: the NAFLD model of India
|
Prasad, Manya
|
|
|
8 |
11 |
p. 969-970
|
artikel
|
| 13 |
Faecal haemoglobin for colorectal cancer detection: is the evidence base complete enough for use as a triage tool?
|
Chandrapalan, Subashini
|
|
|
8 |
11 |
p. 970
|
artikel
|
| 14 |
Further efficacy and safety data for maintenance upadacitinib in ulcerative colitis
|
Atreya, Raja
|
|
|
8 |
11 |
p. 956-957
|
artikel
|
| 15 |
Hepatitis D: a neglected aspect of elimination efforts
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
11 |
p. 955
|
artikel
|
| 16 |
High 10-year mortality in alcohol-related liver disease: where do we go from here?
|
Mellinger, Jessica L
|
|
|
8 |
11 |
p. 961-962
|
artikel
|
| 17 |
HIV pre-exposure prophylaxis as an entry point to the elimination of hepatitis B virus
|
Khwairakpam, Giten
|
|
|
8 |
11 |
p. 967
|
artikel
|
| 18 |
Illuminating the darkness
|
Wortley, Chris
|
|
|
8 |
11 |
p. 974
|
artikel
|
| 19 |
Joint statement in support of hepatitis C human challenge studies
|
Alter, Harvey J
|
|
|
8 |
11 |
p. 967-969
|
artikel
|
| 20 |
Research in Brief
|
Baker, Holly
|
|
|
8 |
11 |
p. 972
|
artikel
|
| 21 |
Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study
|
Ciacci, Carolina
|
|
|
8 |
11 |
p. 1005-1014
|
artikel
|
| 22 |
Taking colonoscopies to the stage at the Edinburgh Fringe
|
Ranscombe, Peter
|
|
|
8 |
11 |
p. 975
|
artikel
|
| 23 |
The place of women in gastrointestinal medicine and surgery: the need for progress
|
Dossa, Fahima
|
|
|
8 |
11 |
p. 965-966
|
artikel
|
| 24 |
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
|
Reynolds, John V
|
|
|
8 |
11 |
p. 1015-1027
|
artikel
|
Tijdschrift beschrijving